Summary

In episode 9, Drs. Grant and Ziva Cooper discuss her research on medicinal cannabis, focusing on gender differences in cannabis response, the therapeutic potential of minor cannabinoids and terpenes, and the opioid-sparing effects of cannabinoids. The conversation highlights the complexities of cannabis research, including regulatory challenges and the need for further studies to clarify the role of cannabinoids in medicine.

Takeaways

• Dr. Ziva Cooper is a leading researcher in medicinal cannabis.

• Gender differences in cannabis response are significant.

• Women may be more sensitive to the pain-relieving effects of cannabis.

• Minor cannabinoids like CBG show promise for therapeutic use.

• Terpenes may enhance the effects of THC without psychoactivity.

• Cannabinoids could potentially reduce opioid use in chronic pain patients.

• Research on cannabinoids faces significant regulatory hurdles.

• Understanding the psychological aspects of pain is crucial.

• The therapeutic potential of cannabinoids is still being explored.

• Future research is needed to clarify the role of cannabinoids in medicine.

Chapters

00:00 CBG for Pain and Appetite Stimulation

00:51 Exploring Sex Differences in Cannabis Response

00:52 Intro

01:24 Understanding Cannabinoids: THC, CBD, and Beyond

01:24 Introduction to Ziva Cooper, PhD

02:17 THC and Sex and Gender Differences

11:09 Minor Cannabinoids, Terpenes and Terpenoids

13:46 Cannabigerol (CBG) for Pain and Appetite Stimulation

20:21 Cannabichromine for Pain

21:48 Exploring Cannabichromine (CBC) and Its Potential

22:21 Understanding Terpenes and Terpendoids (Myrcene and Beta-Caryophyllene)

24:46 The Different Regulatory Status of Terpenes and Terpenoids

26:04 Cannabinoids as Opioid-Sparing Agents

30:22 Cannabinoids and Substance Use Disorders

32:04 The Psychological Experience of Pain

35:14 Advancing Cannabinoid Research in Medicine

38:10 Regulatory Hurdles to Researching Cannabis and Cannabinoids

40:16 Outro